104
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Thyrotropin Receptor Autoantibodies (TSHRAbs): Epitopes, Origins and Clinical Significance

&
Pages 331-337 | Published online: 07 Jul 2009

References

  • Adams, D.D., Knight, A., Knight, J.G. and Laing, P. (1987) "Graves' disease: a paradigm for autoinununity", In: Pinchera, A., Ingbar, S.H., McKenzie, J.M. and Fenzi, GE, eds, Thyroid Autoimmunity (Plenum Press, New York), pp 1–10.
  • Kohn, L.D., Giuliani, C., Montani, V, Napolitano, G., Ohmori, M., Ohta, M., et al. (1995) "Antireceptor immunity", In: Rayner, D. and Champion, B., eds, Thyroid Immunity (R G Landes Biomedical Publishers, Austin/Georgetown, Texas), pp 115–170.
  • Kohn, L.D., Shimura, H., Shimura, Y, Hidaka, A., Giuliani, C., Napolitano, G., et al. (1995) "The thyrotropin receptor", In: Litwack, G., ed, Vitamins and Hormones 50, pp 287–384.
  • Prabhakar, B.S., Fan, J.-L. and Seetharamaiah, G.S. (1997) "Thyrotropin-receptor-mediated diseases: a paradigm for receptor autoimmunity", Immunol. Today 18, 437–442.
  • Davies, T.F., Roti, E., Braverman, L.E. and DeGroot, L.J. (1998) "Thyroid controversy—stimulating antibodies", J. Clin. Endo-crinol. Metal,. 83, 3777–3785.
  • Rapoport, B., Chazenbalk, G.D., Jaume, J.C. and McLachlan, S.M. (1998) "The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies", Endocr. Rev. 19, 673–716.
  • Pinchera, A., Fenzi, GE, Macchia, E., Vitti, P., Monzani, F. and Kohn, L.D. (1982) "Immunoglobulines thyreostimulantes antigens correspondents", Ann. Endcrinol. 43, 520–533.
  • Feldt-Rasmussen, U., Schleusener, H. and Carayon, P. (1994) "Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease", J. ClM. Endocrinol. Metab. 78, 98–102.
  • Di Cerbo, A., Di Paola, R., Menzaghi, C., De Filippis, V., Tahara, K., Corda, D. and Kohn, L.D. (1999) "Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on the TSH receptor", J. Clin. Endocrinol. Metab. 84, 3283–3292.
  • Yavin, E., Yavin, Z., Schneider, M.D., et al. (1981) "Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves' disease", Proc. Natl Acad. Sci. USA 78, 3180–3184.
  • Valente, WA., Yavin, Z., Yavin, E., et al. (1982) "Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies", J. Endocrinol. Invest. 5, 293–301.
  • Valente, W.A., Vitti, P., Yavin, Z., et al. (1982) "Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies", Proc. Nall Acad. Sci. USA 79, 6680–6684.
  • Kohn, L.D., Alvarez, F., Marcocci, C., et al. (1986) "Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease", In: Schwartz, R. and Rose, N., eds, Autoimmunity: Experimental and Clinical Aspects Ann. NY Acad. Sci. 475, pp 157–173.
  • Kohn, L.D., Hoffman, W.H., Tombaccini, D., Marcocci, C., Shimojo, N., Watanabe, Y, et al. (1997) "Characterization of monoclonal thyroid stimulating and thyrotropin binding inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease", J. ClM. Endocrinol. Metab. 82, 3998–4009.
  • Di Cerbo, A. and Corda, D. (1999) "Signaling pathways involved in thyroid hyperfunction and growth in Graves' disease", Biochimie 81, 415–424.
  • Cundiff, J.G., Kaithamana, S., Seetharamaiah, G.S., Baker, J.R., and Prabhakar, B.S. (2001) "Studies using recombinant fragments of human TSH receptor reveal apparent diversity in the binding specificities of antibodies that block TSH binding to its receptor or stimulate thyroid hormone production", J. ClM. Endocrinol. Metab. 86, 3998–4009.
  • Tahara, K., Ban, T., Minegishi, T. and Kohn, L.D. (1991) "Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients", Biochem. Biophys. Res. Commun. 179, 70–77.
  • Nagayama, Y, Wadsworth, H.L., Russo, D., Chazenbalk, G.D. and Rapoport, B. (1991) "Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors", J. Clin. Investig. 88, 336–340.
  • Morris, J.C., Bergert, ER. and McCormick, D.J. (1993) "Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides", J. Biol. Chem. 268, 10900–10905.
  • Sugawa, H., Akamizu, T., Kosugi, S., Ueda, Y, Ohta, C., Okuda, J. and Mori, T. (1995) "Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule", Eur. J. Endocrinol. 133, 283–293.
  • Ueda, Y, Sugawa, H., Akamizu, T., Okuda, J., Ueda, M., Kosugi, S., Ohta, C., Kihou, Y. and Mori, T. (1995) "Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition", Eur. J. Endocrinol. 132, 62–68.
  • Kim, W.B., Cho, BY., Park, RY., Lee, H.K., Kohn, L.D., Tahara, K. and Koh, C.S. (1996) "Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment", J. Clin. Endocrinol. Metab. 81, 1758–1767.
  • Kim, W.B., Chung, H.K., Lee, H.K., Kohn, L.D., Tahara, K. and Cho, B.Y. (1997) "Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyper-thyroidism: therapeutic implications", J. ClM. Endocrinol. Metab. 82, 1953–1959.
  • Watanabe, Y., Tahara, K., Hirai, A., Tada, H., Kohn, L.D. and Amino, N. (1997) "Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor", Thyroid 7, 13–19.
  • Chen, C.-R., Pichurin, P., Nagayama, Y, Latrofa, F., Rapoport, B. and McLachlan, S.M. (2003) "The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim", J. Clin. Investig. 111, 1897–1904.
  • Kosugi, S., Ban, T., Akamizu, T. and Kohn, L.D. (1992) "Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid stimulating antibodies and with thyroid stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors", Mol. Endocrinol. 6, 168–180.
  • Kosugi, S., Ban, T. and Kohn, L.D. (1993) "Identification of thyroid stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor", MoL Endocrinol. 7, 114–130.
  • Kosugi, S., Ban, T., Akamizu, T., et al. (1991) "Site directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors: relationship of functional and immunogenic domains", J. Biol. Chem. 266, 19413–19418.
  • Kosugi, S., Ban, T., Akamizu, T., et al. (1991) "Further characterization of a high-affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients", Biochem. Biophys. Res. Commun. 180, 1118–1124.
  • Kohn, L.D., Kosugi, S., Ban, T., et al. (1992) "Molecular basis for the autoreactivity against thyroid stimulating hormone receptor", Intern. Rev. Immunol. 9, 135–165.
  • Akamizu, T., Inoue, D., Kosugi, S., et al. (1993) "Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids 268-304 in the TSH receptor are involved in the ligand high-affinity, but not in TSH-receptor-specific signal transduction", Endocr. J. 40, 363–372.
  • Akamizu, T., Inoue, D., Kosugi, S., et al. (1994) "Further studies of amino acids(268-304) in thyrotropin (TSH)-lutropin/chorionic gonadotropin (LH/CG) chimeras: cysteine-301 is important in TSH binding and tertiary structure", Thyroid 4, 43–48.
  • Tahara, K., Ishikawa, N., Yamamoto, K., Hirai, A., Ito, K., Tamura, Y., et al. (1997) "Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor", Thyroid 7, 867–877.
  • Ueda, Y, Sugawa, H., Akamizu, T., et al. (1993) "Immunoglobulin G that interferes with thyroid stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor", Thyroid 3, 111–117.
  • Ueda, Y, Sugawa, H., Akamizu, T., et al. (1995) "Presence of heterogeneous thyroid stimulating antibodies in sera from individual Graves' patients as shown by synthesized TSH-R peptide application", Eur. J. EndocrinoL 132, 62–68.
  • Kim, T.Y., Park, Y.J., Park, D.J., Chung, H-K., Kim, W.B., Kohn, L.D. and Cho, BY. (2003) "Prediction of outcome in patients with Graves' disease after antithyroid drug treatment according to epitope heterogeneity of thyroid-stimulating antibodies", J. Clin. EndocrinoL Metal,. 88, 117–124.
  • Kosugi, S., Okajima, F., Ban, T., et al. (1992) "Mutation of alanine 623 in the 3rd cytoplasmic loop of the rat TSH receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies", J. BioL Chem. 267, 24153–24156.
  • Van Sande, J., Lejeune, C., Ludgate, M., et al. (1992) "Thyroid stimulating immunoglobulins, like thyrotropin, activate both the cyclic AMP and the P1P2 cascade in CHO cells expressing the TSH receptor", MoL Cell. Endocrinol. 88, R1—R5.
  • Shimojo, N., Arima, T., Yamaguchi, K-I., Kikuoka, S., Kohn, L.D. and Kohno, Y. (2000) "A novel mouse model of Graves' disease: implications for a role in aberrant MHC class 11 expression in its pathogenesis", Int. Rev. Immunol. 19, 619–631.
  • Kita, M., Ahmad, L., Marians, R.C., Vlase, H., Unger, P., Graves, RN. and Davies, T.F. (1999) "Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease", Endocrinology 140, 1392–1398.
  • Kohn, L.D., Napolitano, G., Singer, D.S., Moltini, M., Scorza, R., Shimojo, N., et al. (2000) "Graves' disease: a host defense mechanism gone awry", Int. Rev. ImmunoL 19, 633–644.
  • Seetharamaiah, G.S., Desai, R.K., Dallas, J.S., et al. (1993) "Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of the human thyrotropin receptor produced using a baculovirus expression system", Autoimmunity 14, 315–320.
  • Morris, J.C., Bergert, ER. and McCormick, D.J. (1993) "Structure function studies of the human thyrotropin receptor: inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides", J. Biol. Chem. 268, 10900–10905.
  • Atassi, M.Z., Manshouri, T. and Sakata, S. (1991) "Localization and synthesis of the hormone binding regions of the human thyrotropin receptor", Proc. Natl Acad. Sci. USA 88, 3613–3617.
  • Ohmori, M., Endo, T. and Onaya, T. (1991) "Development of chicken antibodies toward the human thyrotropin receptor peptides and their bioactivities", Biochem. Biophys. Res. Commun. 174, 399–403.
  • Desai, R.K., Dallas, J.S., Gupta, M.K., et al. (1993) "Dual mechanism of perturbation of thyrotropin mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR derived peptides", J. Clin. Endocrinol. Metab. 77, 658–663.
  • Kung, A.W.C., Lau, K.S. and Kohn, L.D. (2001) "Epitope Mapping of TSH receptor blocking antibodies in Graves' disease which appear during pregnancy", J. Clin. Endocrinol. Metab. 86, 3647–3653.
  • Kung, A.W.C., Lau, KS. and Kohn, L.D. (2000) "Characterization of thyroid-stimulating blocking antibodies which appeared during transient hypothyroidism after radioactive iodine therapy", Thyroid 10, 909–917.
  • Chung, H.-K., Kim, W.B., Park, D.J., Kohn, L.D., Tahara, K. and Cho, B.Y. (1999) "Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies", Thyroid 9, 393–399.
  • Kim, W.B., Chung, H.K., Park, D.J., Lee, H.K., Tahara, K., Kohn, L.D. and Cho, B.Y. (2000) "The prevalence and clinical significance of blocking TSH receptor antibodies in untreated Graves' disease", Thyroid 10, 579–586.
  • Grasso, Y.Z., Kim, MR., Faiman, C., Kohn, L.D., Tahara, K. and Gupta, M.K. (1999) "Epitope heterogeneity of TSH blocking antibodies in Graves' patients as detected with wild type versus chimeric TSH receptors", Thyroid 9, 531–537.
  • Davies, T.F. (1998) "Thyroid-stimulating antibodies predict hyperthyroidism", J. Clin. Endocrinol. Metab. 83, 3777–3781.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.